Advertisement

Topics

Top-News für CRISPR Therapeutics - startet jetzt die nächste Gen-Schere-Welle?

09:08 EDT 16 Apr 2019 | FinanzNachrichten

Erfreuliche Neuigkeiten für CRISPR Therapeutics und den Partner Vertex Pharmaceuticals: Die US-Gesundheitsbehörde FDA gewährt dem Projekt CTX001 gegen ß-Thalassämie den sogenannten "Fast-Track"-Sta...

Original Article: Top-News für CRISPR Therapeutics - startet jetzt die nächste Gen-Schere-Welle?

NEXT ARTICLE

More From BioPortfolio on "Top-News für CRISPR Therapeutics - startet jetzt die nächste Gen-Schere-Welle?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...